General American Investors CO Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

General American Investors CO Inc

  • $1.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$0.94 - $1.89 $564,000 - $1.13 Million
-600,000 Closed
0 $0
Q3 2020

Oct 30, 2020
SELL
$1.5 - $9.38 $168,600 - $1.05 Million
-112,400 Reduced 15.78%
600,000 $1.08 Million
Q1 2020

May 01, 2020
BUY
$3.44 - $7.21 $275,200 - $576,800
80,000 Added 12.65%
712,400 $3.73 Million
Q4 2019

Feb 20, 2020
BUY
$4.29 - $5.64 $321,750 - $423,000
75,000 Added 13.46%
632,400 $3.45 Million
Q1 2019

May 01, 2019
BUY
$5.76 - $8.95 $3.21 Million - $4.99 Million
557,400 New
557,400 $3.87 Million

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track General American Investors CO Inc Portfolio

Follow General American Investors CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email